• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Hepato-renal pathology in pkd2ws25/- mice, an animal model of autosomal dominant polycystic kidney disease.多囊肾病 2 型(PKD2)ws25/- 小鼠的肝肾病理学改变,一种常染色体显性遗传多囊肾病的动物模型。
Am J Pathol. 2010 Mar;176(3):1282-91. doi: 10.2353/ajpath.2010.090658. Epub 2010 Jan 21.
2
Inhibition of Cdc25A suppresses hepato-renal cystogenesis in rodent models of polycystic kidney and liver disease.抑制 Cdc25A 可抑制多囊肾病和肝病啮齿动物模型中的肝-肾囊肿发生。
Gastroenterology. 2012 Mar;142(3):622-633.e4. doi: 10.1053/j.gastro.2011.11.036. Epub 2011 Dec 7.
3
Structural and functional analyses of liver cysts from the BALB/c-cpk mouse model of polycystic kidney disease.来自多囊肾病BALB/c-cpk小鼠模型的肝囊肿的结构和功能分析。
Exp Biol Med (Maywood). 2009 Jan;234(1):17-27. doi: 10.3181/0807-RM-215. Epub 2008 Nov 7.
4
Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate.奥曲肽通过降低胆管细胞环磷腺苷抑制多囊性肝病啮齿动物模型中的肝脏囊肿形成。
Gastroenterology. 2007 Mar;132(3):1104-16. doi: 10.1053/j.gastro.2006.12.039. Epub 2006 Dec 20.
5
The pck rat: a new model that resembles human autosomal dominant polycystic kidney and liver disease.Pck大鼠:一种类似于人类常染色体显性遗传性多囊肾和肝病的新模型。
Kidney Int. 2001 Jan;59(1):126-36. doi: 10.1046/j.1523-1755.2001.00473.x.
6
CXCR2 agonists in ADPKD liver cyst fluids promote cell proliferation.常染色体显性多囊肾病肝囊肿液中的CXCR2激动剂可促进细胞增殖。
Am J Physiol Cell Physiol. 2008 Mar;294(3):C786-96. doi: 10.1152/ajpcell.00457.2007. Epub 2008 Jan 16.
7
Ttc21b deficiency attenuates autosomal dominant polycystic kidney disease in a kidney tubular- and maturation-dependent manner.Ttc21b 缺乏以肾小管和成熟依赖性方式减弱常染色体显性多囊肾病。
Kidney Int. 2022 Sep;102(3):577-591. doi: 10.1016/j.kint.2022.04.034. Epub 2022 May 27.
8
Dnajb11-Kidney Disease Develops from Reduced Polycystin-1 Dosage but not Unfolded Protein Response in Mice.Dnajb11 导致的肾脏疾病是由多囊蛋白-1 表达量降低引起的,而非未折叠蛋白反应。
J Am Soc Nephrol. 2023 Sep 1;34(9):1521-1534. doi: 10.1681/ASN.0000000000000164. Epub 2023 Jun 19.
9
Inhibition of Hedgehog signaling suppresses proliferation and microcyst formation of human Autosomal Dominant Polycystic Kidney Disease cells.Hedgehog 信号通路抑制可抑制人常染色体显性遗传性多囊肾病细胞的增殖和微囊形成。
Sci Rep. 2018 Mar 21;8(1):4985. doi: 10.1038/s41598-018-23341-2.
10
The regulatory 1α subunit of protein kinase A modulates renal cystogenesis.蛋白激酶A的调节性1α亚基调节肾囊肿形成。
Am J Physiol Renal Physiol. 2017 Sep 1;313(3):F677-F686. doi: 10.1152/ajprenal.00119.2017. Epub 2017 Jun 14.

引用本文的文献

1
PKD2: An Important Membrane Protein in Organ Development.PKD2:器官发育中的重要膜蛋白。
Cells. 2024 Oct 17;13(20):1722. doi: 10.3390/cells13201722.
2
Genetics, pathobiology and therapeutic opportunities of polycystic liver disease.多囊肝疾病的遗传学、病理生物学和治疗机会。
Nat Rev Gastroenterol Hepatol. 2022 Sep;19(9):585-604. doi: 10.1038/s41575-022-00617-7. Epub 2022 May 13.
3
Polycystic Liver Disease: Advances in Understanding and Treatment.多囊性肝病:理解与治疗的新进展。
Annu Rev Pathol. 2022 Jan 24;17:251-269. doi: 10.1146/annurev-pathol-042320-121247. Epub 2021 Nov 1.
4
Renal plasticity revealed through reversal of polycystic kidney disease in mice.通过逆转小鼠多囊肾病揭示肾脏的可塑性。
Nat Genet. 2021 Dec;53(12):1649-1663. doi: 10.1038/s41588-021-00946-4. Epub 2021 Oct 11.
5
Intraflagellar Transport Proteins as Regulators of Primary Cilia Length.鞭毛内运输蛋白作为初级纤毛长度的调节因子。
Front Cell Dev Biol. 2021 May 19;9:661350. doi: 10.3389/fcell.2021.661350. eCollection 2021.
6
A mild reduction of food intake slows disease progression in an orthologous mouse model of polycystic kidney disease.在多囊肾病的同源小鼠模型中,适度减少食物摄入量可减缓疾病进展。
Am J Physiol Renal Physiol. 2016 Apr 15;310(8):F726-F731. doi: 10.1152/ajprenal.00551.2015. Epub 2016 Jan 13.
7
Polycystic liver diseases: advanced insights into the molecular mechanisms.多囊肝病:分子机制的前沿见解
Nat Rev Gastroenterol Hepatol. 2014 Dec;11(12):750-61. doi: 10.1038/nrgastro.2014.155. Epub 2014 Sep 30.
8
Centrosomal abnormalities characterize human and rodent cystic cholangiocytes and are associated with Cdc25A overexpression.中心体异常是人类和啮齿动物囊状胆管细胞的特征,并且与 Cdc25A 的过表达相关。
Am J Pathol. 2014 Jan;184(1):110-21. doi: 10.1016/j.ajpath.2013.09.021. Epub 2013 Nov 7.
9
Endothelial dysfunction occurs prior to clinical evidence of polycystic kidney disease.内皮功能障碍发生在多囊肾病的临床证据之前。
Am J Nephrol. 2013;38(3):233-40. doi: 10.1159/000354236. Epub 2013 Aug 30.
10
The zebrafish as a model to study polycystic liver disease.斑马鱼作为研究多囊肝病的模型。
Zebrafish. 2013 Jun;10(2):211-7. doi: 10.1089/zeb.2012.0825. Epub 2013 May 13.

本文引用的文献

1
Cholangiociliopathies: genetics, molecular mechanisms and potential therapies.胆管纤毛病:遗传学、分子机制及潜在疗法
Curr Opin Gastroenterol. 2009 May;25(3):265-71. doi: 10.1097/MOG.0b013e328328f4ff.
2
Hepatic cystogenesis is associated with abnormal expression and location of ion transporters and water channels in an animal model of autosomal recessive polycystic kidney disease.在常染色体隐性多囊肾病动物模型中,肝囊肿形成与离子转运体和水通道的异常表达及定位有关。
Am J Pathol. 2008 Dec;173(6):1637-46. doi: 10.2353/ajpath.2008.080125. Epub 2008 Nov 6.
3
Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate.奥曲肽通过降低胆管细胞环磷腺苷抑制多囊性肝病啮齿动物模型中的肝脏囊肿形成。
Gastroenterology. 2007 Mar;132(3):1104-16. doi: 10.1053/j.gastro.2006.12.039. Epub 2006 Dec 20.
4
Polycystic kidney disease: genes, proteins, animal models, disease mechanisms and therapeutic opportunities.多囊肾病:基因、蛋白质、动物模型、疾病机制与治疗机遇
J Intern Med. 2007 Jan;261(1):17-31. doi: 10.1111/j.1365-2796.2006.01743.x.
5
Polycystic liver disease: new insights into disease pathogenesis.多囊肝病:疾病发病机制的新见解
Hepatology. 2006 May;43(5):906-8. doi: 10.1002/hep.21199.
6
Defining a link with autosomal-dominant polycystic kidney disease in mice with congenitally low expression of Pkd1.在Pkd1先天性低表达的小鼠中确定与常染色体显性多囊肾病的联系。
Am J Pathol. 2006 Jan;168(1):205-20. doi: 10.2353/ajpath.2006.050342.
7
Biliary dysgenesis in the PCK rat, an orthologous model of autosomal recessive polycystic kidney disease.PCK大鼠的胆管发育异常,常染色体隐性多囊肾病的直系同源模型。
Am J Pathol. 2004 Nov;165(5):1719-30. doi: 10.1016/S0002-9440(10)63427-X.
8
Cystic kidney diseases: learning from animal models.囊性肾病:从动物模型中学习。
Nephrol Dial Transplant. 2004 Nov;19(11):2700-2. doi: 10.1093/ndt/gfh533.
9
Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease.降低Pkd1的表达足以引发多囊肾病。
Hum Mol Genet. 2004 Dec 15;13(24):3069-77. doi: 10.1093/hmg/ddh336. Epub 2004 Oct 20.
10
Murine models of polycystic kidney disease: molecular and therapeutic insights.多囊肾病的小鼠模型:分子与治疗见解
Am J Physiol Renal Physiol. 2003 Dec;285(6):F1034-49. doi: 10.1152/ajprenal.00195.2003.

多囊肾病 2 型(PKD2)ws25/- 小鼠的肝肾病理学改变,一种常染色体显性遗传多囊肾病的动物模型。

Hepato-renal pathology in pkd2ws25/- mice, an animal model of autosomal dominant polycystic kidney disease.

机构信息

Miles and Shirley Fiterman Center for Digestive Diseases, Mayo Clinic College of Medicine, 200 First Street, SW, Rochester, MN 55905, USA.

出版信息

Am J Pathol. 2010 Mar;176(3):1282-91. doi: 10.2353/ajpath.2010.090658. Epub 2010 Jan 21.

DOI:10.2353/ajpath.2010.090658
PMID:20093497
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2832149/
Abstract

Polycystic liver diseases, the most important of which are autosomal dominant and autosomal recessive polycystic kidney diseases, are incurable pathological conditions. Animal models that resemble human pathology in these diseases provide an opportunity to study the mechanisms of cystogenesis and to test potential treatments. Here we demonstrate that Pkd2ws25/- mice, an animal model of autosomal dominant polycystic kidney disease, developed hepatic cysts. As assessed by micro-computed tomography scanning of intact livers and by light microscopy of hepatic tissue, hepatic cystic volumes increased from 12.82+/-3.16% (5- to 8-month-old mice) to 21.58+/-4.81% (9- to 12-month-old mice). Renal cystogenesis was more severe at early stages of disease: in 5- to 7-month-old mice, cystic volumes represented 40.67+/-5.48% of kidney parenchyma, whereas in older mice cysts occupied 31.04+/-1.88% of kidney parenchyma. Mild fibrosis occurred only in liver, and its degree was unchanged with age. Hepatic cysts were lined by single or multiple layers of squamous cholangiocytes. Cystic cholangiocyte cilia were short and malformed, whereas in renal cysts they appeared normal. In Pkd2ws25/- mice, mitotic and apoptotic indices in both kidney and liver were increased compared with wild-type mice. In conclusion, Pkd2ws25/- mice exhibit hepatorenal pathology resembling human autosomal dominant polycystic kidney disease and represent a useful model to study mechanisms of cystogenesis and to evaluate treatment options.

摘要

多囊肝疾病,其中最重要的是常染色体显性遗传多囊肾病和常染色体隐性遗传多囊肾病,是无法治愈的病理状况。在这些疾病的动物模型中,与人类病理学相似的动物模型为研究囊肿形成的机制和测试潜在治疗方法提供了机会。在这里,我们证明 Pkd2ws25/- 小鼠,一种常染色体显性遗传多囊肾病的动物模型,发展出了肝囊肿。通过对完整肝脏进行微计算机断层扫描和对肝组织进行光镜检查,肝囊肿体积从 12.82+/-3.16%(5-8 月龄小鼠)增加到 21.58+/-4.81%(9-12 月龄小鼠)。肾囊肿形成在疾病的早期阶段更为严重:在 5-7 月龄的小鼠中,囊肿体积占肾脏实质的 40.67+/-5.48%,而在年龄较大的小鼠中,囊肿占据肾脏实质的 31.04+/-1.88%。轻度纤维化仅发生在肝脏,其程度不随年龄而变化。肝囊肿由单层或多层鳞状胆管细胞排列而成。囊性胆管细胞纤毛短小且畸形,而在肾囊肿中则表现正常。在 Pkd2ws25/- 小鼠中,与野生型小鼠相比,肾脏和肝脏的有丝分裂和凋亡指数均增加。总之,Pkd2ws25/- 小鼠表现出类似于人类常染色体显性遗传多囊肾病的肝肾病理学特征,是研究囊肿形成机制和评估治疗选择的有用模型。